COMPLIANCE. in a Pharmaceutical Industry Perspective. Copenhagen Compliance and Concordance Conference 30th May 2008

Size: px
Start display at page:

Download "COMPLIANCE. in a Pharmaceutical Industry Perspective. Copenhagen Compliance and Concordance Conference 30th May 2008"

Transcription

1 COMPLIANCE in a Pharmaceutical Industry Perspective Copenhagen Compliance and Concordance Conference 30th May 2008 Alejandra Mørk, M.Sc.Pharm., Ph.D, CEO KLIFO A/S

2 Why is Compliance an issue? A succes criteria for the health care professions Important to reduce health care costs (caused by wrong/inappropiate use of drugs) Important to control health care costs (only pay for drugs that are used) Important to improve health

3 Why is Compliance an issue? A succes criteria for the health care professions Important to reduce health care costs (caused by wrong/inappropiate use of drugs) Important to control health care costs (only pay for drugs that are used) Important to improve health Improve therapy

4 Why is Compliance an issue? THE OBLIGATION FOR THE PHARMACEUTICAL INDUSTRY IS TO: Provide medicinal product that are Efficacious Safe Good Quality Patient s Perspective Makes a difference that I take the medicine I can accept and I can manage the side effects It is convenient to handle and take THE AMBITION OF THE PHARMACEUTICAL INDUSTRY IS TO: Improve therapy Regulatory Approval Price, reimbursement, recommendation lists Doctors prescribe Patients use and continue to use the medicine

5 The PATIENT S Perspective Am I ill NO YES Do I need/want treatment NO YES Do I want the treatment offered NO YES Do I understand and manage the treatment NO YES How do I remember to take the medicine right

6 The PATIENT S Perspective Am I ill PHARMACEUTICAL INDUSTRY NO YES Do I need/want treatment NO YES Do I want the treatment offered NO YES Do I understand and manage the treatment NO YES How do I remember to take the medicine right

7 The PATIENT S Perspective IT IS NOT ALL ABOUT DOCTOR-PATIENT RELATION! DOCTOR -Diagnosis - Prescription PHARMACEUTICAL INDUSTRY NURSE -Treatment -Training -Information PRIVATE NETWORK PATIENT ORGANISATIONS - Information PHARMACY -Supply -Information REIMBURSEMENT - Access - Payment

8 Improving Therapy THE OPTIONS FOR THE PHARMACEUTICAL INDUSTRY TO IMPROVE THERAPY RESEARCH PRODUCT DEVELOPMENT INFORMATION AND TRAINING DEVELOPMENT APPROVAL PRICE/ REIMBURSEMENT MARKET INTRODUCTION HIGH QUALITY SUPPLY PROVIDE INFORMATION AND TRAINING MONITOR AND DOCUMENT USAGE SALES NO MAJOR SAFETY PROBLEMS

9 Improving Therapy THE OPTIONS FOR THE PHARMACEUTICAL INDUSTRY TO IMPROVE COMPLIANCE RESEARCH PRODUCT DEVELOPMENT INFORMATION AND TRAINING DEVELOPMENT FORMULATION & DEVICE Minimum: Acceptable disp.form Stable Manufacturable Device no problem CLINICAL DEV. Minimum: Comply with regulatory Requirement challenges - Efficacy - Safety Controlled settings Ideally: Patient convenient Stability at practical conditions Device convenient and supporting compliance Ideally: Knowledge about in-use OBSTACLES! Lack of awareness Not a success criteria Delay of approval Increased risk Confusing data

10 Improving Therapy THE OPTIONS FOR THE PHARMACEUTICAL INDUSTRY TO IMPROVE COMPLIANCE RESEARCH PRODUCT DEVELOPMENT INFORMATION AND TRAINING DEVELOPMENT LAUNCH/MARKETING ACTIVITIY Lack of scientific approach to - Development - Testing

11 Improving Therapy THE OPTIONS FOR THE PHARMACEUTICAL INDUSTRY TO IMPROVE COMPLIANCE HIGH QUALITY SUPPLY PROVIDE INFORMATION AND TRAINING MONITOR AND DOCUMENT USAGE Improved collaboration with other health care professionals Easier flow of information and training to patients -Build on experience cross -countries

12 Improving Therapy THE OPTIONS FOR THE PHARMACEUTICAL INDUSTRY TO IMPROVE COMPLIANCE HIGH QUALITY SUPPLY PROVIDE INFORMATION AND TRAINING MONITOR AND DOCUMENT USAGE OBSTACLES Lack of incentive POST APRROVAL STUDIES Minumum: Regulaotory requirements Price/reimbursement Requirements Idealy: In use experience of drug In use experience of training and information In use experience of health care professionals

13 How to support patients? Usefull information and training Reminder tools Dispensing tools Monitoring Essential the basis for every thing else Helping Hand, Memory caps, Telephones? Dose dispensing, Dispensing boxes Diaries, Electronic capt., Plasma samples Be realistic, Take the patient s perspective, Include development of tools in the development programme

14 How to increase investment in compliance Demand training and information programmes as part of approval process (today required for safety management) Request compliance assessment as pre-requisite for maintaining price and/or reimbursement Award documentation of - efficient training and information progr. - in-use documentation by increase price and/or reimbursement Increase awareness and demand from health care professionals on compliance improving tools Improved methodology to assess effect of training, information and compliance improving tools

15 Compliance Improving therapy Patients focus Create incentives to include compliance in the product development process Devices and tools can be used more and smarter THANK YOU!

Community Pharmacy Multi-compartment Compliance Aids Audit

Community Pharmacy Multi-compartment Compliance Aids Audit Community Pharmacy Multi-compartment Compliance Aids Audit Introduction To comply with the NHS contractual requirements associated with the Clinical Governance Essential Service, pharmacy contractors must

More information

Quality Medication Use in Aboriginal Communities

Quality Medication Use in Aboriginal Communities Quality Medication Use in Aboriginal Communities Lance Emerson, Kathy Bell, Roland Manning 5th National Rural Health Conference Adelaide, South Australia, 14-17th March 1999 Lance Emerson Proceedings Quality

More information

SFHPHARM11 - SQA Unit Code FA2X 04 Prepare extemporaneous medicines for individual use

SFHPHARM11 - SQA Unit Code FA2X 04 Prepare extemporaneous medicines for individual use Prepare extemporaneous medicines for individual use Overview This standard covers your role in preparing extemporaneous medicines for individual use. This involves accurately calculating the quantities

More information

Disability Discrimination Act 1995; Equality Act 2010; and Multicompartment

Disability Discrimination Act 1995; Equality Act 2010; and Multicompartment Contract and IT January 2016 PSNC Briefing 01/16: Equality Act 2010 This briefing updates PSNC Briefing 084/13: Equality Act 2010 on the Equality Act 2010 (incorporating its predecessor legislation the

More information

CHAPTER:2 HOSPITAL PHARMACY. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

CHAPTER:2 HOSPITAL PHARMACY. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY CHAPTER:2 HOSPITAL PHARMACY BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY DEFINITION: The practice of pharmacy within the hospital under the supervision of

More information

Isotretinoin : Review of the Pregnancy Prevention Programme

Isotretinoin : Review of the Pregnancy Prevention Programme Safeguarding public health Isotretinoin : Review of the Pregnancy Prevention Programme HCP WG meeting October 2011: Dr Sarah Mee Isotretinoin: UK RMS Introduction In 2003, European referral led to introduction

More information

International Pharmaceutical Federation Fédération internationale pharmaceutique. Standards for Quality of Pharmacy Services

International Pharmaceutical Federation Fédération internationale pharmaceutique. Standards for Quality of Pharmacy Services International Pharmaceutical Federation Fédération internationale pharmaceutique PO Box 84200, 2508 AE The Hague, The Netherlands Standards for Quality of Pharmacy Services Standards are an important part

More information

The European network evaluation of the PHAR QA framework of competences for...

The European network evaluation of the PHAR QA framework of competences for... The European network evaluation of the PHAR QA framework of competences for... The PHAR QA ( Quality assurance in European pharmacy education and training ) funded by the European Commission, will produce

More information

Chapter 3 Products, Networks, and Payment Unit 4: Pharmacy and Formulary

Chapter 3 Products, Networks, and Payment Unit 4: Pharmacy and Formulary Chapter 3 Products, Networks, and Payment Unit 4: Pharmacy and Formulary In This Unit Topic See Page Unit 4: Pharmacy and Formulary Pharmaceutical Overview 2 Pharmaceutical 3 Drug 4 NOTE: This section

More information

Mix of civil law and common law. Official law database Ministry for justice, culture and local government of Malta

Mix of civil law and common law.  Official law database Ministry for justice, culture and local government of Malta Malta European Region Updated: February 2017 This document contains links to websites where you can find national legislation and health laws. We link to official government legal sources wherever possible.

More information

A Career in Big Pharma. Beatrice Tilt, GSK

A Career in Big Pharma. Beatrice Tilt, GSK A Career in Big Pharma Beatrice Tilt, GSK Media Disclaimer To confirm that the opinions you hear from me are totally my own and do not reflect the views and opinions of GSK in any way. 2 Academic background

More information

Greek-German Cooperation for Research and Innovation. Theodore Tryfon Co-CEO ELPEN Group President, PanHellenic Union Of Pharmaceutical Industries

Greek-German Cooperation for Research and Innovation. Theodore Tryfon Co-CEO ELPEN Group President, PanHellenic Union Of Pharmaceutical Industries Greek-German Cooperation for Research and Innovation Theodore Tryfon Co-CEO ELPEN Group President, PanHellenic Union Of Pharmaceutical Industries Greek Pharmaceutical Industry and Economy 27 hi-end production

More information

What is MTM? Objectives. MTM: Successfully Engaging Eligible Patients. What is MTM? MTM Background. MTM Examples 09/11/2012

What is MTM? Objectives. MTM: Successfully Engaging Eligible Patients. What is MTM? MTM Background. MTM Examples 09/11/2012 MTM: Successfully Engaging Eligible Patients Objectives Explain What MTM is as defined by the Medicare Modernization Act Describe examples of MTM services Recognize the various entities who pay for MTM

More information

Unlicensed medicines ( specials ) Current issues related to unlicensed medicines and a suggested approach to devising a coherent sourcing strategy

Unlicensed medicines ( specials ) Current issues related to unlicensed medicines and a suggested approach to devising a coherent sourcing strategy Unlicensed medicines ( specials ) Current issues related to unlicensed medicines and a suggested approach to devising a coherent sourcing strategy Andrew Tittershill Content Personal introduction. Defining

More information

US Compounding 2515 College Ave Conway, AR (800)

US Compounding 2515 College Ave Conway, AR (800) PCAB Compounding Accreditation Accreditation Summary US Compounding 2515 College Ave Conway, AR 72034 (800) 718 3588 www.uscompounding.com Date of Last In-Pharmacy Survey: June 2008 Next Scheduled In-Pharmacy

More information

Value Added Medicines Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access

Value Added Medicines Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access 09 June 2016 Pr. Mondher Toumi M.D., MSc., Ph.D. Professor in Public Health Department Research Unit EA 3279, Aix-Marseille University

More information

Information shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion.

Information shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion. THE DISCHARGE MEDICINES REVIEW SERVICE Introduction During a stay in hospital a patient s medicines may be changed. Studies show that many patients may experience an error or problem with their medicines

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL SCHEDULING OF SUBSTANCES FOR PRESCRIBING BY AUTHORISED PRESCRIBERS This document provides guidance on the process for amending the Schedules to the Medicines and Related Substances

More information

Technologies in Pharmacology

Technologies in Pharmacology Technologies in Pharmacology OBJECTIVES/RATIONALE Modern health care is increasingly dependent upon technology. Health care workers must be able to select appropriate equipment and instruments and use

More information

Scotia College of Pharmacists Standards of Practice. Practice Directive Prescribing of Drugs by Pharmacists

Scotia College of Pharmacists Standards of Practice. Practice Directive Prescribing of Drugs by Pharmacists Scotia College of Pharmacists Standards of Practice Practice Directive Prescribing of Drugs by Pharmacists September 2014 ACKNOWLEDGEMENTS This Practice Directives document has been developed by the Prince

More information

DANISH PHARMACONOMIST A PROFESSION WITH A PROFESSIONAL PROFILE

DANISH PHARMACONOMIST A PROFESSION WITH A PROFESSIONAL PROFILE DANISH PHARMACONOMIST A PROFESSION WITH A PROFESSIONAL PROFILE BACKGROUND AND AIMS This project focuses on the core competences Danish pharmaconomists receive through their education and their work areas.

More information

Foundation Pharmacy Framework

Foundation Pharmacy Framework Association of Pharmacy Technicians UK Foundation Pharmacy Framework A framework for professional development in foundation across pharmacy APTUK Foundation Pharmacy Framework The Professional Leadership

More information

PCAB Compounding Accreditation Accreditation Summary

PCAB Compounding Accreditation Accreditation Summary PCAB Compounding Accreditation Accreditation Summary McGuff Compounding Pharmacy Services, Inc Santa Ana, California compounding pharmacy 2921 W. MacArthur Blvd., Ste.142 Santa Ana, CA 92704 Telephone:877-444-1133

More information

Title Administration of Oral Medication in the Community by Support Workers Purpose Background dignity of risk Scope Disclaimer Copyright ACIA 2017

Title Administration of Oral Medication in the Community by Support Workers Purpose Background dignity of risk Scope Disclaimer Copyright ACIA 2017 Title Purpose Background Administration of Oral Medication in the Community by Support Workers This guideline is to assist service providers (organisations and individuals), Participants, stakeholders,

More information

Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess.

Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess. Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess. Number Outcome SBA SBA-1 SBA-1.1 SBA-1.2 SBA-1.3 SBA-1.4 SBA-1.5 SBA-1.6 SBA-1.7

More information

Day Activity Health Services (DAHS) Forms

Day Activity Health Services (DAHS) Forms Day Activity Health Services (DAHS) Forms 1 Background In March 2012,DADS began working on revisions to Form 3050, including a decision to develop a separate health assessment form. 2 DAHS Forms Changes

More information

This is the consultation responses analysis put together by the Hearing Aid Council and considered at their Council meeting on 12 November 2008

This is the consultation responses analysis put together by the Hearing Aid Council and considered at their Council meeting on 12 November 2008 Analysis of responses - Hearing Aid Council and Health Professions Council consultation on standards of proficiency and the threshold level of qualification for entry to the Hearing Aid Audiologists/Dispensers

More information

Community Pharmacy in 2016/17 and beyond

Community Pharmacy in 2016/17 and beyond Community Pharmacy in 2016/17 and beyond Stakeholder briefing sessions 1 CONTENTS Contents This presentation describes our vision for community pharmacy, and outlines proposals for achieving that vision,

More information

New Jersey issues rules to chill drug manufacturer payments to prescribers

New Jersey issues rules to chill drug manufacturer payments to prescribers New Jersey issues rules to chill drug manufacturer payments to prescribers January 10, 2018 The New Jersey Attorney General plans to finalize new limits on payments and other benefits that New Jersey licensed

More information

Underlying principles of the CVS Caremark Formulary Development and Management Process include the following:

Underlying principles of the CVS Caremark Formulary Development and Management Process include the following: Formulary Development and Management at CVS Caremark Development and management of drug formularies is an integral component in the pharmacy benefit management (PBM) services CVS Caremark provides to health

More information

NeedyMeds

NeedyMeds NeedyMeds www.needymeds.org Find help with the cost of medicine Thank you for downloading this patient assistance document from NeedyMeds. We hope this program will help you get the medicine you need.

More information

Practice Spotlight. Children's Hospital Central California Madera, California

Practice Spotlight. Children's Hospital Central California Madera, California Practice Spotlight Children's Hospital Central California Madera, California http://www.childrenscentralcal.org Richard I. Sakai, Pharm.D., FASHP, FCSHP Director of Pharmacy Services IN YOUR VIEW, HOW

More information

Mandatory Medicaid Services

Mandatory Medicaid Services Florida Medicaid: A Case for Modernization October 5, 2004 Medicaid Structure Federal Medicaid laws mandate certain benefits for certain populations Medicaid programs vary considerably from state to state,

More information

ADMINISTRATION OF ORAL MEDICATIONS IN THE COMMUNITY BY ATTENDANT CARE SUPPORT WORKERS

ADMINISTRATION OF ORAL MEDICATIONS IN THE COMMUNITY BY ATTENDANT CARE SUPPORT WORKERS Title Purpose ADMINISTRATION OF ORAL MEDICATIONS IN THE COMMUNITY BY ATTENDANT CARE SUPPORT WORKERS This guideline is to assist: Attendant care service providers (organisations and individuals), participants,

More information

PRESCRIBING SUPPORT TECHNICIAN:

PRESCRIBING SUPPORT TECHNICIAN: PRESCRIBING SUPPORT TEAM AUDIT: CARDURA XL (Updated Sept 09) DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY Cardura XL is a once daily, extended release preparation of doxazosin

More information

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Managing Treatment With Oral Oncology Medications. An Educational Toolkit for Health Care Providers

Managing Treatment With Oral Oncology Medications. An Educational Toolkit for Health Care Providers Managing Treatment With Oral Oncology Medications An Educational Toolkit for Health Care Providers Acknowledgment Novartis Pharmaceuticals Corporation would like to thank Jody Pelusi, PhD, FNP, AOCNP,

More information

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland patient CMP nurse doctor For further information relating to Nurse Prescribing please contact the Nurse

More information

Pharmacy Medicine Use Review What s it all about?

Pharmacy Medicine Use Review What s it all about? Pharmacy Medicine Use Review What s it all about? 1. What is it? 1.1 Medicine use Review has been introduced under the Advanced Services tier of the New Pharmacy Contract in England & Wales. The aim of

More information

Following are some common questions and answers from the hospital perspective regarding Manufacturing and Compounding :

Following are some common questions and answers from the hospital perspective regarding Manufacturing and Compounding : Health Canada Manufacturing and Compounding Drug Products in Canada: A Policy Framework : Guidelines for P.E.I. Community and Hospital Pharmacists October 2001 In response to pharmacists questions about

More information

Shared Care Agreements for Medicines

Shared Care Agreements for Medicines Shared Care Agreements for Medicines Author: Scott Garden, Chief Pharmacist, Acute Services Version: 1.0 Authorised by: NHS Fife Area Drug and Therapeutics Committee Date of Authorisation: Review Date:

More information

Electronic Prescribing:

Electronic Prescribing: Sponsored by: Electronic Prescribing: How Do We Get to the Tipping Point? AHIP Business Forum November 19, 2008 1 Making the Case For Electronic Prescribing 2 Electronic Prescribing Prescribe Transmit

More information

CHARTER ON PATIENTS & HEALTH SERVICE PROVIDERS RIGHTS & RESPONSIBILITIES

CHARTER ON PATIENTS & HEALTH SERVICE PROVIDERS RIGHTS & RESPONSIBILITIES CHARTER ON PATIENTS & HEALTH SERVICE PROVIDERS RIGHTS & RESPONSIBILITIES INTRODUCTION Health, defined as a complete state of physical, mental, social and spiritual wellbeing is a fundamental right. According

More information

ASSOCIATION FOR ACCESSIBLE MEDICINES Code of Business Ethics. March 2018

ASSOCIATION FOR ACCESSIBLE MEDICINES Code of Business Ethics. March 2018 ASSOCIATION FOR ACCESSIBLE MEDICINES Code of Business Ethics March 2018 Introduction Improving patient access to affordable medicines is a core value of companies that develop and manufacture generic and

More information

Frequently Asked Questions

Frequently Asked Questions 1. What is dispensing? Frequently Asked Questions DO I NEED A PERMIT? Dispensing means the procedure which results in the receipt of a prescription drug by a patient. Dispensing includes: a. Interpretation

More information

Medicaid Update Special Edition Budget Highlights New York State Budget: Health Reform Highlights

Medicaid Update Special Edition Budget Highlights New York State Budget: Health Reform Highlights Page 1 of 6 New York State April 2009 Volume 25, Number 4 Medicaid Update Special Edition 2009-10 Budget Highlights David A. Paterson, Governor State of New York Richard F. Daines, M.D. Commissioner New

More information

Supporting self-administration of medication in the care home setting

Supporting self-administration of medication in the care home setting B143. November 2016 2.0 Community Interest Company Supporting self-administration of medication in the care home setting Care home residents should have the opportunity to make informed decisions about

More information

Derbyshire Medicines Management on behalf of Southern Derbyshire CCG, Erewash CCG, North Derbyshire CCG & Hardwick CCG

Derbyshire Medicines Management on behalf of Southern Derbyshire CCG, Erewash CCG, North Derbyshire CCG & Hardwick CCG Derbyshire Medicines Management on behalf of Southern Derbyshire CCG, Erewash CCG, rth Derbyshire CCG & Hardwick CCG CCG Position Statement on the Supply of Multi-Compartment Compliance Aids (MCAs) There

More information

Executive Summary and A Vision for Health Care

Executive Summary and A Vision for Health Care N AT I O N A L C O M M U N I T Y P H A R M A C I S T S A S S O C I AT I O N Executive Summary and A Vision for Health Care The face of independent pharmacy 2006 NCPA-Pfizer Digest-In-Brief November 2006

More information

UK strategy for reclassification of medicines. Dr Sarah Branch, Deputy Director, VRMM Division

UK strategy for reclassification of medicines. Dr Sarah Branch, Deputy Director, VRMM Division UK strategy for reclassification of medicines Dr Sarah Branch, Deputy Director, VRMM Division MHRA commitment to reclassification Reclassification of medicines to non-prescription when safe to do so and

More information

SFHPHARM27 - SQA Unit Code FA2P 04 Undertake an in-process accuracy check of assembled prescribed items prior to the final accuracy check

SFHPHARM27 - SQA Unit Code FA2P 04 Undertake an in-process accuracy check of assembled prescribed items prior to the final accuracy check Undertake an in-process accuracy check of assembled prescribed items prior to the final accuracy check Overview This standard describes the skills, knowledge and understanding required to demonstrate competence

More information

What are patient-driven approaches / self-management? Here are the opportunities:

What are patient-driven approaches / self-management? Here are the opportunities: What are patient-driven approaches / self-management? Here are the opportunities: Technologies that allow patients / citizens to manage their condition using technology. Use of smartphones / tablets /

More information

Patient Section All fields are required. Please print clearly and complete all information.

Patient Section All fields are required. Please print clearly and complete all information. Lilly Cares Foundation Patient Assistance Program PO Box 13185 La Jolla, CA 92039 Phone: 1-800-545-6962 Fax: 1-844-431-6650 www.lillycares.com Patient Section All fields are required. Please print clearly

More information

NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION)

NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) CONTENTS POLICY SUMMARY... 2 1. SCOPE... 4 2. AIM... 4 3. BACKGROUND... 4 4. POLICY STATEMENTS... 5 4.1. GENERAL STATEMENTS... 5 4.2 UNLICENSED

More information

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE SECTION 9(a) UNLICENSED MEDICINES BACKGROUND and PURPOSE Under the Medicines Act 1968 (EEC Directive 65/65), a company

More information

Unlicensed Medicines Policy

Unlicensed Medicines Policy Unlicensed Medicines Policy This procedural document supersedes: PAT/MM 4 v.3 Policy and Procedure for the Use of Unlicensed Medicines Did you print this document yourself? The Trust discourages the retention

More information

Arizona Department of Health Services Licensing and CMS Deficient Practices

Arizona Department of Health Services Licensing and CMS Deficient Practices Arizona Department of Health Services Licensing and CMS Deficient Practices Connie Belden, RN., Bureau of Medical Facility Licensing August 8, 2013 General Comments Deficient Practices per visit Trend

More information

Research themes for the pharmaceutical sector

Research themes for the pharmaceutical sector CENTRE FOR THE HEALTH ECONOMY Research themes for the pharmaceutical sector Macquarie University s Centre for the Health Economy (MUCHE) was established to undertake innovative research on health, ageing

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL SA GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINES This document is intended to serve as guidance on the requirements for Good Manufacturing Practice in South Africa. This

More information

PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK

PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK 0 CONTENTS Course Description Period of Learning in Practice Summary of Competencies Guide to Assessing Competencies Page 2 3 10 14 Course

More information

Guidance on the provision of pharmacy services affected by religious and moral beliefs

Guidance on the provision of pharmacy services affected by religious and moral beliefs Guidance on the provision of pharmacy services affected by religious and moral beliefs September 2010 Guidance on the provision of pharmacy services affected by religious and moral beliefs The General

More information

Association of Pharmacy Technicians United Kingdom

Association of Pharmacy Technicians United Kingdom Please find below APTUKs views to the proposals for change in Community Pharmacy as discussed at the Community Pharmacy in 2016/2017 and beyond stakeholder meeting on the 4 th February 2016 Introduction

More information

The Mexico City Principles For Voluntary Codes of Business Ethics in the Biopharmaceutical Sector

The Mexico City Principles For Voluntary Codes of Business Ethics in the Biopharmaceutical Sector The Mexico City Principles For Voluntary Codes of Business Ethics in the Biopharmaceutical Sector E thical interactions help ensure that medical decisions are made in the best interests of patients. For

More information

Pharmacy Schools Council. Strategic Plan November PhSC. Pharmacy Schools Council

Pharmacy Schools Council. Strategic Plan November PhSC. Pharmacy Schools Council Pharmacy Schools Council Strategic Plan 2017 2021 November 2017 PhSC Pharmacy Schools Council Executive summary The Pharmacy Schools Council is seeking to engage with all stakeholders to support and enhance

More information

FERRIS STATE UNIVERSITY COLLEGE OF PHARMACY APPROVED BY FACULTY AUGUST 20, 2014

FERRIS STATE UNIVERSITY COLLEGE OF PHARMACY APPROVED BY FACULTY AUGUST 20, 2014 FERRIS STATE UNIVERSITY COLLEGE OF PHARMACY APPROVED BY FACULTY AUGUST 20, 2014 1.0.0 DOMAIN 1 - FOUNDATIONAL KNOWLEDGE 1.1.0 Learner (Learner) Apply knowledge from the foundational sciences (i.e., pharmaceutical,

More information

Nova Scotia College of Pharmacists. Standards of Practice. Prescribing Drugs

Nova Scotia College of Pharmacists. Standards of Practice. Prescribing Drugs Nova Scotia College of Pharmacists Standards of Practice November 2015 Acknowledgements Acknowledgements This Standards of Practice document has been developed by the Nova Scotia College of Pharmacists

More information

CONSENSUS FRAMEWORK FOR ETHICAL COLLABORATION

CONSENSUS FRAMEWORK FOR ETHICAL COLLABORATION CONSENSUS FRAMEWORK FOR ETHICAL COLLABORATION November 2016 ABOUT CORD The Canadian Organization for Rare Disorders (CORD) provides a strong common voice to advocate for health policy and a healthcare

More information

Contribute to society, and. Act as stewards of their professions. As a pharmacist or as a pharmacy technician, I must:

Contribute to society, and. Act as stewards of their professions. As a pharmacist or as a pharmacy technician, I must: Code of Ethics Preamble Pharmacists and pharmacy technicians play pivotal roles in the continuum of health care provided to patients. The responsibility that comes with being an essential health resource

More information

Study definition of CPD

Study definition of CPD 1. ABSTRACT There is widespread recognition of the importance of continuous professional development (CPD) and life-long learning (LLL) of health professionals. CPD and LLL help to ensure that professional

More information

September 16 th, Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852

September 16 th, Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852 September 16 th, 2013 Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Docket No. FDA-2013-N-0502: Standardizing and Evaluating Risk

More information

Repeat Prescribing for Practice Staff. Richard Hassett Prescribing Support Technician Inverclyde CHP

Repeat Prescribing for Practice Staff. Richard Hassett Prescribing Support Technician Inverclyde CHP Repeat Prescribing for Practice Staff Richard Hassett Prescribing Support Technician Inverclyde CHP Introduction Aim To highlight and encourage the sharing of good practice in repeat prescribing systems

More information

Fundamentals of Medication Therapy Management (MTM) Services By Bruce R. Siecker, Ph.D., R.Ph.

Fundamentals of Medication Therapy Management (MTM) Services By Bruce R. Siecker, Ph.D., R.Ph. Fundamentals of Medication Therapy Management (MTM) Services By Bruce R. Siecker, Ph.D., R.Ph. Bruce Siecker is president of Paradigm Research & Advisory Services, Inc. based in Stone Ridge, Virginia.

More information

December 12, [Submitted online at:

December 12, [Submitted online at: Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS-4157-P Room C4-26-05 7500 Security Boulevard Baltimore, MD 21244-1850 [Submitted online at: www.regulations.gov]

More information

NEW STANDARD OF PRACTICE PRESCRIBING

NEW STANDARD OF PRACTICE PRESCRIBING NEW STANDARD OF PRACTICE PRESCRIBING Notice to College Members June 21, 2018 Following consultation with College Members, on June 16, 2018 Council of the College approved a new Standard of Practice on

More information

Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making

Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making Royal Pharmaceutical Society response The Royal Pharmaceutical Society (RPS) is the professional

More information

RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER ADVANCED PRACTICE NURSES & CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS

RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER ADVANCED PRACTICE NURSES & CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES & CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions

More information

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section. TITLE MEDICATION ORDERS SCOPE Provincial APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Provincial Medication Management Committee PARENT DOCUMENT TITLE, TYPE AND NUMBER Not applicable

More information

Criteria / Observations

Criteria / Observations Observations Index It is the company s individual decision to sponsor / participate in the event. Companies belonging to the EFPIA membership should be mindful of the rules and provisions that apply when

More information

Reducing Pharmaceutical Waste March 26, 2009

Reducing Pharmaceutical Waste March 26, 2009 Reducing Pharmaceutical Waste March 26, 2009 Prescription medications are critical to maintaining health and improving the quality of life for millions of Americans. Not all medications dispensed to patients,

More information

What does governance look like in homecare?

What does governance look like in homecare? What does governance look like in homecare? Dr David Cousins PhD FRPharmS Head of Pa)ent Safety, Healthcare at Home Ltd This Satellite is sponsored by Healthcare at Home Ltd Definitions Clinical governance

More information

REGULATION IN THE TELEHEALTHCARE SECTOR IN RUSSIA: LEGAL DEVELOPMENTS

REGULATION IN THE TELEHEALTHCARE SECTOR IN RUSSIA: LEGAL DEVELOPMENTS REGULATION IN THE TELEHEALTHCARE SECTOR IN RUSSIA: LEGAL DEVELOPMENTS www.gratanet.com The Federal Law No. 242-FZ dated 29 July 2017 amended certain legislative acts of the Russian Federation on the use

More information

This document provides information on conducting the Perindopril New To Therapy Program using GuildCare software.

This document provides information on conducting the Perindopril New To Therapy Program using GuildCare software. Perindopril New To Therapy Program PROTOCOL This document provides information on conducting the Perindopril New To Therapy Program using GuildCare software. April 2015 Table of Contents Executive Summary...

More information

Researched Medicines Industry Association of New Zealand Incorporated. Submission on Pharmacist Prescribers

Researched Medicines Industry Association of New Zealand Incorporated. Submission on Pharmacist Prescribers Researched Medicines Industry Association of New Zealand Incorporated Submission on Pharmacist Prescribers July 2010 Researched Medicines Industry Association of New Zealand Incorporated Level 8, 86-90

More information

specialty pharmacy: reining in costs and improving health outcomes

specialty pharmacy: reining in costs and improving health outcomes specialty pharmacy: reining in costs and improving health outcomes Overview Specialty drugs are bringing great advances in health care and dramatically improving the medical outlook for employees and covered

More information

Practising as a midwife in the UK

Practising as a midwife in the UK Practising as a midwife in the UK An overview of midwifery regulation CONTENTS Introduction 3 Section 1: Education 4 Section 2: Joining the register and maintaining registration 6 Section 3: Standards

More information

340B Drug Program Summary

340B Drug Program Summary Summary Congress created section 340B of the Public Health Service Act in 1992 to allow eligible health care providers known as Covered Entities to stretch scarce Federal resources, reaching more patients

More information

Job Description. Basic Grade Pharmacy Technician

Job Description. Basic Grade Pharmacy Technician Job Description Job Title Basic Grade Pharmacy Technician Job Grade Basic Grade Location of Post Pharmacy Department, Temple Street Children s University Hospital Competition Reference HR382 Notes to Applicants

More information

Transnational Skill Standards Pharmacy Assistant

Transnational Skill Standards Pharmacy Assistant Transnational Skill Standards Pharmacy Assistant REFERENCE ID: HSS/ Q 5401 Mapping for Pharmacy Assistant (HSS/ Q 5401) with UK SVQ level 2 Qualification Certificate in Pharmacy Service Skills Link to

More information

We understand that as the new regulatory environment evolves checks and balance will be available to provide challenge to change.

We understand that as the new regulatory environment evolves checks and balance will be available to provide challenge to change. Rebalancing Medicines Legislation and Pharmacy regulation: draft Orders under section 60 of the Health Act 1999 Royal Pharmaceutical Society (RPS) Response General comments: The Royal Pharmaceutical Society

More information

Pharmacy Technicians Practice and Procedures

Pharmacy Technicians Practice and Procedures (Question): Which of the following best describes the practice of pharmacy? (A): Providing pharmaceutical information to the public. (B): Art and science of preparing and dispensing medications. (C): Art

More information

ADVANCED SERVICES (Pharmacy Contractors)

ADVANCED SERVICES (Pharmacy Contractors) ADVANCED SERVICES (Pharmacy Contractors) MEDICINE USE REVIEWS 1 Background 1.1 The South (South West) Area Team for Devon Cornwall & Isles of Scilly (DCIoS) supports the provision of the advanced service

More information

Long Term Care Group Services Organizations Not Just for Nursing Home Providers Anymore

Long Term Care Group Services Organizations Not Just for Nursing Home Providers Anymore Long Term Care Group Services Organizations Not Just for Nursing Home Providers Anymore Presented by: Denny Sherrill, Vice President, GeriMed John Schutte, President, GeriMed 2:15 p.m. - 3:45 p.m., Tuesday,

More information

THE CODE. Professional standards of conduct, ethics and performance for pharmacists in Northern Ireland. Effective from 1 March 2016

THE CODE. Professional standards of conduct, ethics and performance for pharmacists in Northern Ireland. Effective from 1 March 2016 THE CODE Professional standards of conduct, ethics and performance for pharmacists in Northern Ireland Effective from 1 March 2016 PRINCIPLE 1: ALWAYS PUT THE PATIENT FIRST PRINCIPLE 2: PROVIDE A SAFE

More information

Medicines Management Policy

Medicines Management Policy Medicines Management Policy Name of Policy: Purpose of Policy: Directorate responsible for Policy Name & Title of Author: Medicines Management Policy The Southern HSC Trust recognises that almost all patients

More information

HCA 302 Module 5 Lecture Notes The Pharmaceutical Industry and Health Care Workforce

HCA 302 Module 5 Lecture Notes The Pharmaceutical Industry and Health Care Workforce HCA 302 Module 5 Lecture Notes The Pharmaceutical Industry and Health Care Workforce Why are pharmaceuticals important? The Pharmaceutical Industry has influence, in part because it represents 10% of the

More information

Fundamentals of Self-Limiting Conditions Prescribing for Manitoba Pharmacists. Ronald F. Guse Registrar College of Pharmacists of Manitoba (CPhM)

Fundamentals of Self-Limiting Conditions Prescribing for Manitoba Pharmacists. Ronald F. Guse Registrar College of Pharmacists of Manitoba (CPhM) Fundamentals of Self-Limiting Conditions Prescribing for Manitoba Pharmacists Ronald F. Guse Registrar College of Pharmacists of Manitoba (CPhM) 1 Learning Objectives Upon successful completion of this

More information

The roles of the Department of Health and NHS England in relation to community pharmacy. PSNC Community Pharmacy Conference 2013

The roles of the Department of Health and NHS England in relation to community pharmacy. PSNC Community Pharmacy Conference 2013 The roles of the and NHS England in relation to community pharmacy PSNC Community Pharmacy Conference 2013 24 April 2013 The s (DH) role: The helps people to live better for longer. We lead, shape and

More information

ST. JAMES S HOSPITAL

ST. JAMES S HOSPITAL ST. JAMES S HOSPITAL Job Title: Grade: Area Of Assignment: Reporting Relationship: Anti-microbial Pharmacist Senior Pharmacist Pharmacy Department Deputy Director of Pharmacy Salary Scale: 61, 031-70,

More information

Step-Edit Training Program

Step-Edit Training Program Step-Edit Training Program What are step-edit programs? Why are they important? How can you address them? Step-edit programs affect your bottom line Step-edit programs create hassles for pharmacists, nursing

More information

Medicaid Prescribed Drug Program. Spending Control Initiatives

Medicaid Prescribed Drug Program. Spending Control Initiatives Medicaid Prescribed Drug Program Spending Control Initiatives For Quarters Ended September 30, 2010 and December 31, 2010 Table of Contents Purpose of Report... 1 Executive Summary... 2 Pharmacy Appropriations

More information